Lin, X., Zhu, H., Zheng, Z. (2025). Sugemalimab plus chemotherapy versus chemotherapy for advanced gastric cancer in China: a cost-effectiveness analysis. Scientific Reports. https://doi.org/10.1038/s41598-025-18030-w